BWLSA
NTRA icon

Blue Water Life Science Advisors’s Natera NTRA Stock Holding History

Blue Water Life Science Advisors’s Portfolio NTRA Stock Details NTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36M Sell
34,494
-10,300
-23% -$2.2M 5.9% 7
2026
Q1 		$8.96M Sell
44,794
-96,700
-68% -$20.8M 7.18% 7
2025
Q4 		$32.4M Hold
141,494
– – 20.34% 2
2025
Q3 		$22.8M Sell
141,494
-25,000
-15% -$3.96M 20.78% 3
2025
Q2 		$28.1M Sell
166,494
-42,000
-20% -$6.55M 22.26% 1
2025
Q1 		$29.5M Sell
208,494
-46,300
-18% -$7.44M 29.22% 2
2024
Q4 		$40.3M Sell
254,794
-36,300
-12% -$5.29M 35.71% 1
2024
Q3 		$37M Sell
291,094
-212,000
-42% -$24.3M 32.5% 1
2024
Q2 		$54.5M Hold
503,094
– – 52.98% 1
2024
Q1 		$46M Buy
503,094
+105,658
+27% +$7.95M 43.28% 1
2023
Q4 		$24.9M Sell
397,436
-400,000
-50% -$20M 21.81% 1
2023
Q3 		$35.3M Sell
797,436
-84,000
-10% -$4.28M 33.31% 1
2023
Q2 		$42.9M Hold
881,436
– – 28.95% 1
2023
Q1 		$48.9M Hold
881,436
– – 32.36% 1
2022
Q4 		$35.4M Sell
881,436
-223,145
-20% -$9.19M 23.79% 1
2022
Q3 		$48.4M Buy
1,104,581
+175,000
+19% +$8.33M 19.54% 2
2022
Q2 		$32.9M Sell
929,581
-198,400
-18% -$7.35M 17.89% 2
2022
Q1 		$45.9M Buy
1,127,981
+405,800
+56% +$24.4M 21.78% 1
2021
Q4 		$67.4M Buy
722,181
+168,800
+31% +$17.5M 20.63% 1
2021
Q3 		$61.7M Buy
553,381
+95,400
+21% +$10.9M 20.06% 1
2021
Q2 		$52M Buy
457,981
+129,145
+39% +$13.2M 19.56% 1
2021
Q1 		$33.4M Buy
328,836
+44,035
+15% +$4.83M 16.31% 3
2020
Q4 		$28.3M Buy
+284,801
New +$23.8M 16.64% 2

Other funds holding NTRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Water Life Science Advisors's NTRA Position: Q2 2026 in Review

Blue Water Life Science Advisors reduced its Natera (NTRA) stake by 23% in Q2 2026, selling an estimated $2.2M and leaving 34,494 shares worth $9.36M. The position accounts for 5.9% of the portfolio, ranked #7.

Blue Water Life Science Advisors first reported a position in NTRA in Q4 2020 and has held it in 23 quarters since. The position peaked at $67.4M in Q4 2021. 844 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • Blue Water Life Science Advisors held 34,494 shares of Natera worth $9.36M as of Q2 2026.
  • Blue Water Life Science Advisors sold 10,300 Natera shares in Q2 2026, an estimated $2.2M.
  • Natera made up 5.9% of Blue Water Life Science Advisors's portfolio in Q2 2026, its #7 holding.
  • Blue Water Life Science Advisors first reported a position in Natera in Q4 2020 and has held it in 23 quarters since.
  • Blue Water Life Science Advisors's Natera position peaked at $67.4M in Q4 2021.
  • 844 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.